{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:11:18Z","timestamp":1791871878830,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>In addition to neurological symptoms glioblastoma (GBM) patients can experience psychiatric complaints, which are often hard to recognize and difficult to treat. Research on psychiatric symptoms during glioblastoma treatment is limited, but can have significant impact on quality of life, treatment processes and even survival. The aim of this study is to explore the incidence of clinically relevant psychiatric symptoms, during glioblastoma treatment and active surveillance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Medical records of 302 GBM patients were reviewed from diagnostic surgery until discontinuation of treatment or active surveillance. Clinical relevance was defined as psychiatric symptoms that interfered with the oncological treatment and required referral to a psychiatrist. \u201cReferred\u201d versus \u201cnon-referred\u201d GBM patients were compared using the Pearson Chi-Square test, Fisher\u2019s Exact Test or Mann Whitney-U test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Psychiatric symptoms occurred in 11.5% of patients during glioblastoma treatment or active surveillance, most often mood or behavioral symptoms, followed by psychotic symptoms. Referral occurred mainly during concomitant chemoradiation or adjuvant chemotherapy (64.3%). In 28.6% of patients psychiatric symptoms were thought to be attributive to medication. Treatment was discontinued in 17.9% of patients and temporarily interrupted in 3.6%. Possible risk factors included male gender, history of psychiatric disorder, postoperative delirium, non-frontal tumor location, anti-epileptic drug use at baseline and corticosteroid initiation during treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The found incidence of 11.5% and the high number of patients discontinuing treatment due to psychiatric symptoms justify more research in this, to date, understudied topic in scientific literature. Further prospective studies are needed to identify risk factors and unravel possible effects on survival.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-023-04326-2","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T08:01:35Z","timestamp":1683792095000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study"],"prefix":"10.1007","volume":"163","author":[{"given":"L. K. P.","family":"Regli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M. H.","family":"Huijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C. O. S.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. B. P.","family":"Eekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Hovinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H. M. E.","family":"Anten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-2202","authenticated-orcid":false,"given":"M. P. G.","family":"Broen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"issue":"3","key":"4326_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Rud\u00e0 R, Short S, Smits M, Taphoorn M, von Deimling A, Wick W (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncoly 18(3):170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncoly"},{"key":"4326_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1560","author":"C McKinnon","year":"2021","unstructured":"McKinnon C, Nandhabalan M, Murray SA, Plaha P (2021) Glioblastoma: clinical presentation, diagnosis, and management. BMJ. https:\/\/doi.org\/10.1136\/bmj.n1560","journal-title":"BMJ"},{"issue":"3","key":"4326_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5498\/wjp.v5.i3.273","volume":"5","author":"S Madhusoodanan","year":"2015","unstructured":"Madhusoodanan S, Ting MB, Farah T, Ugur U (2015) Psychiatric aspects of brain tumors: a review. World J Psychiatry 5(3):273. https:\/\/doi.org\/10.5498\/wjp.v5.i3.273","journal-title":"World J Psychiatry"},{"issue":"10","key":"4326_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/nejmoa043330","journal-title":"N Engl J Med"},{"key":"4326_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s65874","author":"F Boele","year":"2015","unstructured":"Boele F, Rooney A, Grant R, Klein M (2015) Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatric Dis Treat. https:\/\/doi.org\/10.2147\/ndt.s65874","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"10","key":"4326_CR6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1586\/ern.10.94","volume":"10","author":"S Madhusoodanan","year":"2010","unstructured":"Madhusoodanan S, Opler MG, Moise D, Gordon J, Danan DM, Sinha A, Babu RP (2010) Brain tumor location and psychiatric symptoms: is there any association? A meta-analysis of published case studies. Expert Rev Neurother 10(10):1529\u20131536. https:\/\/doi.org\/10.1586\/ern.10.94","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"4326_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jama.1938.02790100012004","volume":"110","author":"M Keschner","year":"1938","unstructured":"Keschner M, Bender MB, Strauss I (1938) Mental symptoms associated with brain tumor: a study of 530 verified cases. J Am Med Assoc 110(10):714\u2013718","journal-title":"J Am Med Assoc"},{"issue":"3","key":"4326_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/brainsci11030301","volume":"11","author":"F Ghandour","year":"2021","unstructured":"Ghandour F, Squassina A, Karaky R, Diab-Assaf M, Fadda P, Pisanu C (2021) Presenting psychiatric and neurological symptoms and signs of brain tumors before diagnosis: a systematic review. Brain Sci 11(3):301. https:\/\/doi.org\/10.3390\/brainsci11030301","journal-title":"Brain Sci"},{"key":"4326_CR9","unstructured":"Kaplan, H.; Sadock, B. 1998 Mental disorders due to general medical condition. In Synopsis of Psychiatry; Lippincott Williams & Wilkins: Philadelphia, PA, USA,; pp. 350\u2013364."},{"issue":"1","key":"4326_CR10","first-page":"19","volume":"163","author":"CM Filley","year":"1995","unstructured":"Filley CM, Kleinschmidt-DeMasters BK (1995) Neurobehavioral presentations of brain neoplasms. West J Med 163(1):19\u201325","journal-title":"West J Med"},{"issue":"2","key":"4326_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/10401230490453770","volume":"16","author":"S Madhusoodanan","year":"2004","unstructured":"Madhusoodanan S, Danan D, Brenner R, Bogunovic O (2004) Brain tumor and psychiatric manifestations: a case report and brief review. Annal Clinical Psychiatry: Off J Am Acad Clin Psychiatrists 16(2):111\u2013113. https:\/\/doi.org\/10.1080\/10401230490453770","journal-title":"Annal Clinical Psychiatry: Off J Am Acad Clin Psychiatrists"},{"issue":"4","key":"4326_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/14737175.7.4.343","volume":"7","author":"S Madhusoodanan","year":"2007","unstructured":"Madhusoodanan S, Danan D, Moise D (2007) Psychiatric manifestations of brain tumors: diagnostic implications. Expert Rev Neurother 7(4):343\u2013349. https:\/\/doi.org\/10.1586\/14737175.7.4.343","journal-title":"Expert Rev Neurother"},{"issue":"S1","key":"4326_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0924-9338(15)32059-9","volume":"30","author":"S Mardaga","year":"2015","unstructured":"Mardaga S, Al Bassir M, Bracke J, Dutilleux A, Born J (2015) Psychiatric symptoms in patients with brain tumors. Eur Psychiatry 30(S1):1\u20131. https:\/\/doi.org\/10.1016\/S0924-9338(15)32059-9","journal-title":"Eur Psychiatry"},{"issue":"4","key":"4326_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/nop\/npv040","volume":"3","author":"H Zwinkels","year":"2016","unstructured":"Zwinkels H, Dirven L, Vissers T, Habets E, Vos MJ, Reijneveld JC, van den Bent MJ, Taphoorn M (2016) Prevalence of changes in personality and behavior in adult glioma patients: a systematic review. Neuro-Oncol Pract 3(4):222\u2013231. https:\/\/doi.org\/10.1093\/nop\/npv040","journal-title":"Neuro-Oncol Pract"},{"issue":"1","key":"4326_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-021-03747-1","volume":"153","author":"PB van der Meer","year":"2021","unstructured":"van der Meer PB, Koekkoek J, van den Bent MJ, Dirven L, Taphoorn M (2021) Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints. J Neurooncol 153(1):89\u201398. https:\/\/doi.org\/10.1007\/s11060-021-03747-1","journal-title":"J Neurooncol"},{"issue":"1","key":"4326_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnci\/djq458","volume":"103","author":"AG Rooney","year":"2011","unstructured":"Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61\u201376. https:\/\/doi.org\/10.1093\/jnci\/djq458","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"4326_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.293.5.557","volume":"293","author":"Chang, S. M., Parney, I. F., Huang, W., Anderson, F. A., Jr, Asher, A. L., Bernstein, M., Lillehei, K. O., Brem, H., Berger, M. S., Laws, E. R., & Glioma Outcomes Project Investigators","year":"2005","unstructured":"Chang, S. M., Parney, I. F., Huang, W., Anderson, F. A., Jr, Asher, A. L., Bernstein, M., Lillehei, K. O., Brem, H., Berger, M. S., Laws, E. R., & Glioma Outcomes Project Investigators (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557\u2013564. https:\/\/doi.org\/10.1001\/jama.293.5.557","journal-title":"JAMA"},{"issue":"6","key":"4326_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/neuros\/nyx606","volume":"83","author":"PM Flanigan","year":"2018","unstructured":"Flanigan PM, Jahangiri A, Weinstein D, Dayani F, Chandra A, Kanungo I, Choi S, Sankaran S, Molinaro AM, McDermott MW, Berger MS, Aghi MK (2018) Postoperative delirium in glioblastoma patients. Neurosurgery 83(6):1161\u20131172. https:\/\/doi.org\/10.1093\/neuros\/nyx606","journal-title":"Neurosurgery"},{"key":"4326_CR19","doi-asserted-by":"publisher","DOI":"10.3171\/CASE22362","author":"JP Andrews","year":"2022","unstructured":"Andrews JP, Wozny TA, Yue JK, Wang DD (2022) Improved psychotic symptoms following resection of amygdalar low-grade glioma: illustrative case. J Neurosurg Case Lessons. https:\/\/doi.org\/10.3171\/CASE22362","journal-title":"J Neurosurg Case Lessons"},{"issue":"2","key":"4326_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archneur.1967.00470260003001","volume":"17","author":"N Malamud","year":"1967","unstructured":"Malamud N (1967) Psychiatric disorder with intracranial tumors of limbic system. Arch Neurol 17(2):113\u2013123. https:\/\/doi.org\/10.1001\/archneur.1967.00470260003001","journal-title":"Arch Neurol"},{"issue":"10","key":"4326_CR21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.4065\/81.10.1361","volume":"81","author":"TP Warrington","year":"2006","unstructured":"Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81(10):1361\u20131367. https:\/\/doi.org\/10.4065\/81.10.1361","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4326_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/cns.13.65","volume":"3","author":"FW Boele","year":"2014","unstructured":"Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ (2014) Symptom management and quality of life in glioma patients. CNS Oncol 3(1):37\u201347. https:\/\/doi.org\/10.2217\/cns.13.65","journal-title":"CNS Oncol"},{"issue":"6","key":"4326_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/nop\/npac053","volume":"9","author":"KCF Figuracion","year":"2022","unstructured":"Figuracion KCF, Halasz LM, Lam NY, Goldberg M, Stuckey J, Failor RA, Knowles LM, Artherholt S, Chou B, Francis CE, Knight K, Kaur M, Sadak T, McGranahan T (2022) Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendations. Neuro-Oncol Pract 9(6):475\u2013486. https:\/\/doi.org\/10.1093\/nop\/npac053","journal-title":"Neuro-Oncol Pract"},{"issue":"1","key":"4326_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/ipj.ipj_72_19","volume":"28","author":"S Srivastava","year":"2019","unstructured":"Srivastava S, Bhatia MS, Gaur A, Singh G (2019) Psychiatric and cognitive correlates of quality of life among persons with primary brain tumors. Ind Psychiatry J 28(1):141\u2013147. https:\/\/doi.org\/10.4103\/ipj.ipj_72_19","journal-title":"Ind Psychiatry J"},{"issue":"6","key":"4326_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1634\/theoncologist.2009-0291","volume":"15","author":"MJ Taphoorn","year":"2010","unstructured":"Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15(6):618\u2013626. https:\/\/doi.org\/10.1634\/theoncologist.2009-0291","journal-title":"Oncologist"},{"issue":"20","key":"4326_CR26","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1200\/JCO.2001.19.20.4037","volume":"19","author":"M Klein","year":"2001","unstructured":"Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol: off J Am Soc Clin Oncol 19(20):4037\u20134047. https:\/\/doi.org\/10.1200\/JCO.2001.19.20.4037","journal-title":"J Clin Oncol: off J Am Soc Clin Oncol"},{"issue":"3","key":"4326_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpsychores.2009.04.010","volume":"68","author":"C Leue","year":"2010","unstructured":"Leue C, Driessen G, Strik JJ, Drukker M, Stockbr\u00fcgger RW, Kuijpers PM, Masclee AA, van Os J (2010) Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention. J Psychosom Res 68(3):295\u2013302. https:\/\/doi.org\/10.1016\/j.jpsychores.2009.04.010","journal-title":"J Psychosom Res"},{"issue":"7","key":"4326_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaoncol.2020.1466","volume":"6","author":"JE Berchuck","year":"2020","unstructured":"Berchuck JE, Meyer CS, Zhang N, Berchuck CM, Trivedi NN, Cohen B, Wang S (2020) Association of mental health treatment with outcomes for US Veterans diagnosed with non-small cell lung cancer. JAMA Oncol 6(7):1055\u20131062. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1466","journal-title":"JAMA Oncol"},{"issue":"2","key":"4326_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.21037\/apm.2016.03.06","volume":"5","author":"WW Fu","year":"2016","unstructured":"Fu WW, Popovic M, Agarwal A, Milakovic M, Fu TS, McDonald R, Fu G, Lam M, Chow R, Cheon S, Pulenzas N, Lam H, DeAngelis C, Chow E (2016) The impact of psychosocial intervention on survival in cancer: a meta-analysis. Annal Palliat Med 5(2):93\u2013106","journal-title":"Annal Palliat Med"},{"issue":"12","key":"4326_CR30","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1212\/01.wnl.0000098892.33018.4c","volume":"61","author":"M Klein","year":"2003","unstructured":"Klein M, Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, van der Ploeg HM, Heimans JJ (2003) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61(12):1796\u20131798. https:\/\/doi.org\/10.1212\/01.wnl.0000098892.33018.4c","journal-title":"Neurology"},{"issue":"4","key":"4326_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00415-020-10303-w","volume":"268","author":"E van Kessel","year":"2021","unstructured":"van Kessel E, Huenges Wajer IMC, Ruis C, Seute T, Fonville S, De Vos FYFL, Verhoeff JJC, Robe PA, van Zandvoort MJE, Snijders TJ (2021) Cognitive impairments are independently associated with shorter survival in diffuse glioma patients. J Neurol 268(4):1434\u20131442. https:\/\/doi.org\/10.1007\/s00415-020-10303-w","journal-title":"J Neurol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04326-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T09:13:21Z","timestamp":1685524401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04326-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04326-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional review boards (reference number METC2021-3034 (MUMC\u2009+) and METC Z2022014 (ZMC)) of the participating centers and conducted in accordance with the Helsinki declaration and national legislation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}